R&D Systems™ Recombinant Human Angiopoietin-like 4 N-Terminal Frag

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Angiopoietin-like 4 N-Terminal Frag is derived from CHO. The Recombinant Human Angiopoietin-like 4 N-Terminal Frag has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: Q9BY76
• Formulation: Lyophilized from a 0.2μm filtered solution in MOPS, NaCl and CHAPS
• Gene ID (Entrez): 51129
• Molecular Weight (g/mol): 17kDa
• Name: Angiopoietin-like Protein 4/ANGPTL4 N-Terminal Fragment
• Preparation Method: Reconstitute at 100μg/mL in PBS.
• Quality Control Testing: SDS-PAGE: 32-70kDa, reducing conditions
• Quantity: 50μg
• Source: Chinese Hamster Ovary cell line,CHO-derived human Angiopoietin-like protein, (N-terminus) 4/ANGPTL4 protein, (N-terminus) Human ANGPTL4 (Gly26-Arg161) Accession &Num; Q9BY76 GGGSGGGSGGGS 6-His tag (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Termination: Gly26
• Without Additives: Carrier Protein
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 85%, by SDS-PAGE with silver staining